Dentsply Sirona Reports Q3 2026 Revenue Decline and Lowers Full-Year Guidance
Dentsply Sirona (XRAY) reported third-quarter net sales of $836 million, a 7.6% decrease year-over-year, driven by lower dental volumes and the absence of Byte revenue. Adjusted earnings per share fell to $0.29 from $0.42 in the prior year quarter, reflecting both reduced sales and increased strategic investments in research and development. The company has lowered its full-year adjusted EPS guidance to a range of $1.20 to $1.30, down from previous estimates of $1.40 to $1.50, citing regional headwinds in Europe, the Middle East, and Africa (EMEA). While gross margins expanded due to accounting refinements and manufacturing efficiencies, higher distribution and freight costs pressured adjusted EBITDA margins.
Tickers: $XRAY
Topics: adjusted EPS guidance revision net sales revenue decline